Last updated: September 2026
Indocyanine green angiography (ICGA) uses a dye that binds strongly to plasma proteins and emits in the near-infrared spectrum — this lets it penetrate the retinal pigment epithelium and image the choroidal circulation in a way FFA and OCTA cannot match, which is exactly where ICGA retains an essential, largely unchallenged role.
Unlike FFA, ICGA has not been substantially displaced by OCTA — OCTA's imaging depth and its inability to show true dye leakage/hyperpermeability limit its usefulness for exactly the diseases where ICGA is most valuable (PCV, CSCR pachychoroid assessment, inflammatory choroidopathies). In current practice, ICGA and OCTA are complementary rather than competing: OCTA for structural/flow detail, ICGA for functional leakage and hyperpermeability of the choroidal circulation.
Key reference: fundamentals of ICGA in choroidal vascular disease remain consistent across recent retina imaging literature; PCV and pachychoroid spectrum disease continue to rely on ICGA as the reference standard.
📘 Want the exam-ready deep dive? This topic, and much more is covered in Ophthalmology Explorer (A High-Yield Clinical Reference for Ophthalmology Residents, Fellows & Board Exams) — available on Kindle. See all my books.
Want to know more about treatment? Read about Retina Treatment at Sadbhaav or book a consultation with Dr. Dhaval Patel.